Selected research
Industry Research
Captopril Tablets Industry Research Report 2026
Market perspective
The global Captopril Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Captopril Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Captopril Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Captopril Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Captopril Tablets include Accord Healthcare, Apotex, A-S Medication Solutions, Baker Cummins, Camber Pharmaceutical, Par Pharmaceutical, Preferred Pharmaceuticals, Pidi Pharmaceutical and Changzhou Pharmaceutical Factory, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Captopril Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Captopril Tablets Market by Company
Accord Healthcare
Apotex
A-S Medication Solutions
Baker Cummins
Camber Pharmaceutical
Par Pharmaceutical
Preferred Pharmaceuticals
Pidi Pharmaceutical
Changzhou Pharmaceutical Factory
Sandoz
TEVA
Zhongjie Pharmaceutical
Captopril Tablets Segment by Type
25mg Tablet
50mg Tablet
Others
Captopril Tablets Segment by Application
Clinics
Hospitals
Others
Captopril Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Captopril Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Captopril Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Captopril Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Captopril Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Captopril Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Captopril Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 25mg Tablet
- 50mg Tablet
- Others
Applications
- Clinics
- Hospitals
- Others
Companies covered
- Accord Healthcare
- Apotex
- A-S Medication Solutions
- Baker Cummins
- Camber Pharmaceutical
- Par Pharmaceutical
- Preferred Pharmaceuticals
- Pidi Pharmaceutical
- Changzhou Pharmaceutical Factory
- Sandoz
- TEVA
- Zhongjie Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Captopril Tablets Market Size (2021-2032)
- 2.2.2 Global Captopril Tablets Sales (2021-2032)
- 2.2.3 Global Captopril Tablets Market Average Price (2021-2032)
- 2.3 Captopril Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 25mg Tablet
- 2.3.3 50mg Tablet
- 2.3.4 Others
- 2.4 Captopril Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinics
- 2.4.3 Hospitals
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Captopril Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Captopril Tablets Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Captopril Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Captopril Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Captopril Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Captopril Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Captopril Tablets, Product Type & Application
- 3.8 Global Manufacturers of Captopril Tablets, Established Date
- 3.9 Global Captopril Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Accord Healthcare
- 4.1.1 Accord Healthcare Company Information
- 4.1.2 Accord Healthcare Business Overview
- 4.1.3 Accord Healthcare Captopril Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Accord Healthcare Captopril Tablets Product Portfolio
- 4.1.5 Accord Healthcare Recent Developments
- 4.2 Apotex
- 4.2.1 Apotex Company Information
- 4.2.2 Apotex Business Overview
- 4.2.3 Apotex Captopril Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Apotex Captopril Tablets Product Portfolio
- 4.2.5 Apotex Recent Developments
- 4.3 A-S Medication Solutions
- 4.3.1 A-S Medication Solutions Company Information
- 4.3.2 A-S Medication Solutions Business Overview
- 4.3.3 A-S Medication Solutions Captopril Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 A-S Medication Solutions Captopril Tablets Product Portfolio
- 4.3.5 A-S Medication Solutions Recent Developments
- 4.4 Baker Cummins
- 4.4.1 Baker Cummins Company Information
- 4.4.2 Baker Cummins Business Overview
- 4.4.3 Baker Cummins Captopril Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Baker Cummins Captopril Tablets Product Portfolio
- 4.4.5 Baker Cummins Recent Developments
- 4.5 Camber Pharmaceutical
- 4.5.1 Camber Pharmaceutical Company Information
- 4.5.2 Camber Pharmaceutical Business Overview
- 4.5.3 Camber Pharmaceutical Captopril Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Camber Pharmaceutical Captopril Tablets Product Portfolio
- 4.5.5 Camber Pharmaceutical Recent Developments
- 4.6 Par Pharmaceutical
- 4.6.1 Par Pharmaceutical Company Information
- 4.6.2 Par Pharmaceutical Business Overview
- 4.6.3 Par Pharmaceutical Captopril Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Par Pharmaceutical Captopril Tablets Product Portfolio
- 4.6.5 Par Pharmaceutical Recent Developments
- 4.7 Preferred Pharmaceuticals
- 4.7.1 Preferred Pharmaceuticals Company Information
- 4.7.2 Preferred Pharmaceuticals Business Overview
- 4.7.3 Preferred Pharmaceuticals Captopril Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Preferred Pharmaceuticals Captopril Tablets Product Portfolio
- 4.7.5 Preferred Pharmaceuticals Recent Developments
- 4.8 Pidi Pharmaceutical
- 4.8.1 Pidi Pharmaceutical Company Information
- 4.8.2 Pidi Pharmaceutical Business Overview
- 4.8.3 Pidi Pharmaceutical Captopril Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pidi Pharmaceutical Captopril Tablets Product Portfolio
- 4.8.5 Pidi Pharmaceutical Recent Developments
- 4.9 Changzhou Pharmaceutical Factory
- 4.9.1 Changzhou Pharmaceutical Factory Company Information
- 4.9.2 Changzhou Pharmaceutical Factory Business Overview
- 4.9.3 Changzhou Pharmaceutical Factory Captopril Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Changzhou Pharmaceutical Factory Captopril Tablets Product Portfolio
- 4.9.5 Changzhou Pharmaceutical Factory Recent Developments
- 4.10 Sandoz
- 4.10.1 Sandoz Company Information
- 4.10.2 Sandoz Business Overview
- 4.10.3 Sandoz Captopril Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sandoz Captopril Tablets Product Portfolio
- 4.10.5 Sandoz Recent Developments
- 4.11 TEVA
- 4.11.1 TEVA Company Information
- 4.11.2 TEVA Business Overview
- 4.11.3 TEVA Captopril Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 TEVA Captopril Tablets Product Portfolio
- 4.11.5 TEVA Recent Developments
- 4.12 Zhongjie Pharmaceutical
- 4.12.1 Zhongjie Pharmaceutical Company Information
- 4.12.2 Zhongjie Pharmaceutical Business Overview
- 4.12.3 Zhongjie Pharmaceutical Captopril Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Zhongjie Pharmaceutical Captopril Tablets Product Portfolio
- 4.12.5 Zhongjie Pharmaceutical Recent Developments
5 Global Captopril Tablets Market Scenario by Region
- 5.1 Global Captopril Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Captopril Tablets Sales by Region: 2021-2032
- 5.2.1 Global Captopril Tablets Sales by Region: 2021-2026
- 5.2.2 Global Captopril Tablets Sales by Region: 2027-2032
- 5.3 Global Captopril Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Captopril Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Captopril Tablets Revenue by Region: 2027-2032
- 5.4 North America Captopril Tablets Market Facts & Figures by Country
- 5.4.1 North America Captopril Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Captopril Tablets Sales by Country (2021-2032)
- 5.4.3 North America Captopril Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Captopril Tablets Market Facts & Figures by Country
- 5.5.1 Europe Captopril Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Captopril Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Captopril Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Captopril Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Captopril Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Captopril Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Captopril Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Captopril Tablets Market Facts & Figures by Country
- 5.7.1 South America Captopril Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Captopril Tablets Sales by Country (2021-2032)
- 5.7.3 South America Captopril Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Captopril Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Captopril Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Captopril Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Captopril Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Captopril Tablets Sales by Type (2021-2032)
- 6.1.1 Global Captopril Tablets Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Captopril Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Captopril Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Captopril Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Captopril Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Captopril Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Captopril Tablets Sales by Application (2021-2032)
- 7.1.1 Global Captopril Tablets Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Captopril Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Captopril Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Captopril Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Captopril Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Captopril Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Captopril Tablets Value Chain Analysis
- 8.1.1 Captopril Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Captopril Tablets Production Mode & Process
- 8.2 Captopril Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Captopril Tablets Distributors
- 8.2.3 Captopril Tablets Customers
9 Global Captopril Tablets Analyzing Market Dynamics
- 9.1 Captopril Tablets Industry Trends
- 9.2 Captopril Tablets Industry Drivers
- 9.3 Captopril Tablets Industry Opportunities and Challenges
- 9.4 Captopril Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst